Is Messenger RNA Patent-Eligible?
Amid ongoing patent disputes over the mRNA platform, a significant scientific question remains unanswered: whether mRNA itself even is patent eligible.
patents
-
Read more: Is Messenger RNA Patent-Eligible? -
Read more: Visualizing the Growing Intersection of Life Sciences and Computing Patents in the US from 1976-2021 Visualizing the Growing Intersection of Life Sciences and Computing Patents in the US from 1976-2021
Mapping the growth of U.S. innovation in the life sciences and computing fields from 1976-2021 through publicly available patent data.
-
Read more: COVID-19 Vaccine Patent Infringement? The Battle Between Moderna and Pfizer/BioNTech Continues COVID-19 Vaccine Patent Infringement? The Battle Between Moderna and Pfizer/BioNTech Continues
An explanation of the key patents at stake in the intellectual property dispute between Moderna and Pfizer/BioNTech over COVID-19 vaccines.
-
Read more: The Secret World of mRNA: HDT Bio Corp v. Emcure and Access to Next-Gen mRNA The Secret World of mRNA: HDT Bio Corp v. Emcure and Access to Next-Gen mRNA
The future of public health in an “RNA world” is on trial in a trade secrecy dispute worth $950 million.
-
Read more: No Take-Backs: Moderna’s Attempt to Renege on its Vaccine Patent Pledge No Take-Backs: Moderna’s Attempt to Renege on its Vaccine Patent Pledge
This post explains why Moderna’s cynical attempt to take back its COVID-19 vaccine patent pledge should fail.
-
Read more: Monthly Round-Up of What to Read on Pharma Law and Policy Monthly Round-Up of What to Read on Pharma Law and Policy
Interesting empirical studies, policy analyses, and editorials on health law and policy issues from April 2022.
-
Read more: Graduate Students’ Curricula Should Include Intellectual Property Graduate Students’ Curricula Should Include Intellectual Property
Science and engineering graduate students’ curricula should include cross-disciplinary studies in intellectual property (IP).
-
Read more: The Risk of Pervasive Trade Secret Practices Within the Life Sciences The Risk of Pervasive Trade Secret Practices Within the Life Sciences
Trade secrets offer a number of benefits for life sciences companies compared to patents, such as theoretical indefinite intellectual property protection.
-
Read more: Will NIH Learn from Myriad when Settling Its mRNA Inventorship Dispute with Moderna? Will NIH Learn from Myriad when Settling Its mRNA Inventorship Dispute with Moderna?
The NIH, which funded much of Moderna’s research on the COVID-19 vaccine, should be assertive in exerting control over the results of this research.
-
Read more: In Academia, Innovators Receive Unfair Compensation for Their Discoveries In Academia, Innovators Receive Unfair Compensation for Their Discoveries
In academia, many of the scientists who are recognized as inventors on patents see little economic gain from these agreements.
